Financial Summary (All financials)
In millions, except per share items | Jun-30-09 | Jun-30-08 | Jun-30-07 | Jun-30-06 | Jun-30-05 |
Revenues | 66.5 | 67.5 | 47.4 | 22.7 | 16.2 |
Revenue growth | -1.4% | 42.3% | 109.3% | 39.6% | |
Cost of goods sold | 13.0 | 11.4 | 8.8 | 4.3 | 2.9 |
Gross profit | 53.5 | 56.1 | 38.6 | 18.4 | 13.3 |
Gross margin | 80.4% | 83.1% | 81.5% | 81.2% | 82.0% |
Sales and marketing | 54.6 | 56.9 | 38.2 | 20.7 | 11.7 |
Research and development | 9.6 | 9.3 | 7.8 | 4.3 | 5.6 |
General and administrative | 10.2 | 9.9 | 7.0 | 5.0 | 7.0 |
EBIT | -20.9 | -20.0 | -14.3 | -11.6 | -10.9 |
EBIT margin | -31.4% | -29.7% | -30.1% | -51.2% | -67.4% |
Pre-tax income | -20.9 | -29.2 | -13.4 | -11.4 | -10.7 |
Income taxes | 0.2 | 0.3 | 0.2 | 0.0 | 0.0 |
Net income | -21.1 | -29.5 | -13.6 | -11.4 | -10.7 |
Net margin | -31.7% | -43.8% | -28.6% | -50.3% | -65.8% |
|
Diluted EPS | ($0.46) | ($0.94) | ($3.54) | ($3.96) | ($4.73) |
Shares outstanding (diluted) | 46.3 | 31.3 | 3.8 | 2.9 | 2.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|